QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,501 signal articles · 104 in last 24h · 107,954 total before filter · latest 1h ago
104last 24h
2584last 7d
487● bullish (7d)
239● bearish (7d)
202publishers
AllMacro222Earnings1613M&A119Regulatory16Product10Analyst25
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Moderna Stock Rises After mRNA Flu Shot Approval
The Wall Street Journal3d agoneutral
Moderna Stock Rises After mRNA Flu Shot Approval

Shares in Moderna ticked higher after the biotech secured Food and Drug Administration approval for its mRNA flu vaccine for use in adults aged 50 and older. The FDA's decision capped an arduous seven-month process that included a rare refusal by the regulator to consider the shot.

Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2
Insider Monkey3d agoneutral
Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 and the Russell 2000 Growth Index up 25.7% in Q2, fueled by AI […]

Reuters3d agoneutral
Optical networking firm Lumilens valued at $5.5 billion in latest funding round

Optical networking startup Lumilens said on Thursday it was valued at $5.51 billion in its latest funding round, ‌as surging investment in AI data centers fuels demand for ‌high-speed connectivity technologies. The San Jose, California-based company designs and manufactures optical and networking products ​that help data centers move data faster while using less power. It raised more than $700 million in the Series C funding round co-led by Atreides Management, Bain Capital Ventures, Meritech, Seligman Ventures and Spark Capital, bringing its ‌total funding to more than $900 ⁠million.

SpaceX stuck in tight range as lockup expiry adds to post-IPO woes
Reuters3d agoneutral
SpaceX stuck in tight range as lockup expiry adds to post-IPO woes

SpaceX shares seesawed on Thursday as investors weighed the impact of insider selling on the stock, which has had a ‌turbulent run since its market debut. When a company goes public, its executives, employees and early investors are ​typically barred from selling their shares for up to 180 days under lock-up agreements designed to curb volatility and support the stock. SpaceX, however, had an unusual arrangement under which up to 20% of the restricted shares could be sold starting Thursday, the second trading day after its second-quarter earnings release.

SpaceX's $300 Billion Mobile Opportunity Is Harder Than It Looks
Trefis3d agoneutral
SpaceX's $300 Billion Mobile Opportunity Is Harder Than It Looks

SpaceX (SPCX) has executed reusable rocket landings, built the world's largest satellite constellation, and is looking to enable computing in orbit. Now, after transforming space infrastructure, the company is setting its sights on a far more conventional but enormous market: consumer wireless, a U.S. industry that generates over $300 billion in annual revenue.

Is DaVita (DVA) a Great Value Stock Right Now?
Zacks3d agoneutral
Is DaVita (DVA) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.